As myeloproliferative neoplasms are a group of progressive blood cancers that can develop quickly into more serious hematological diseases, hear what community practices need to know about treating these patients quickly and the impact that timeliness of care can have on patient outcomes. In this episode, CANCERBUZZ speaks with Srdan Verstovsek, MD, PhD, United Energy Resources Inc. professor of Medicine and hematologist oncologist at MD Anderson Cancer Center, University of Texas, about when to begin therapeutic care for MPNs and the urgency of treatment.
“We learned from experience over the last ten to twenty years that early intervention—when things are not too bad—will actually help us achieve the goals of therapy. We will have a chance to significantly decrease the size of the spleen or improve the quality of life if we do not wait for patient to be terribly sick. So, early intervention in terms of identifying the problem, objectivizing it, [and recognizing] that the symptoms are there, [indicate that we] should start the therapy now—why wait?”–Srdan Verstovsek, MD, PhD
This is the second video podcast in a four-episode series on myeloproliferative neoplasms in connection with the education program “Advancing Care for Patients with Myeloproliferative Neoplasms (MPNs).” This episode is supported by Incyte.
Srdan Verstovsek, MD, PhD
Professor of Medicine, Department of Leukemia, Division of Cancer Medicine
Hematologist Oncologist
MD Anderson Cancer Center, University of Texas
Houston, TX
Resources:
Social Determinants of Health in Metastatic Breast Cancer
Overcoming Barriers to Holistic Survivorship Care for Immunotherapy Patients
Integrating Genetic Counselors in Routine Genitourinary Care
A Multidisciplinary Approach to Anemia Management in High-Risk MDS and AML
Improving Care Delivery to Patients Newly Diagnosed with Breast Cancer
Highlights from the ACCC Working Summit: Advancing CAR T-Cell Therapy Care Continuity and Collaborative Patient Education
Care Action Plans for People with Cancer
Beyond the Brush: Navigating Dental Care in Head & Neck Cancer
Navigating the Operational Challenges of Treatment with Bispecific Antibodies
Policy Perspectives on Biomarker Testing Coverage for 2024
Open Enrollment: Best Practices for End-of-Year Prep
Disparities in Accessing Care for AML Patients: Challenges and Solutions
Clarifying the Role of Maintenance Therapy
A Conversation With ACCC’s Outgoing and Incoming Presidents at the ACCC 50th Annual Meeting and Cancer Center Business Summit
LIVE from AMCCBS: White House Update
LIVE from AMCCBS: Capitol Hill Update
LIVE from AMCCBS: Institute for Comprehensive Cancer Care Services
LIVE from AMCCBS: New Payments for Patient Navigation
LIVE from AMCCBS: Financial Advocacy Resources
Making the Case for Head & Neck Cancer Patient Care Navigators
Create your
podcast in
minutes
It is Free
The Psychic Elephant Radio Podcast
DNA Today: A Genetics Podcast
Museum of the Missing
Sasquatch Chronicles
Hidden Brain